テアフラビンは,DDIT4をダウン調節することによって,結腸癌細胞の増殖と糖分解を阻害する
Huanqing Li1, Songhua Bei1, Yanqing Mo1,2
1Endoscopy Center, Minhang Hospital, Fudan University, Shanghai, China.
Drug development research
|September 5, 2025
まとめ
テアフラビン (TF) は,DDIT4発現を抑制し,細胞の糖分解を標的として,結腸直腸がん (CRC) の進行を効果的に抑制する. この天然の化合物は,細胞の侵入,移動,増殖を減らすことで,CRC治療の有望性を示しています.
科学分野:
- 腫瘍学
- 分子生物学
- 生物化学
背景:
- 結腸直腸がん (CRC) は,有意な転移の可能性があり,患者のアウトカムが悪い悪性腫瘍です.
- 有効な治療戦略を開発するために,CRCの進行を支える分子メカニズムを理解することは極めて重要です.
研究 の 目的:
- 結腸直腸がん (CRC) 細胞に対するセアフラビン (TF) の抗癌効果を調査する.
- CRCの進行と代謝におけるDDIT4の役割に焦点を当てて,分子メカニズムを解明する.
主な方法:
- RNAシーケンシング,差異的遺伝子発現分析,および遺伝子プロファイリングのためのVenn図を用いた.
- CCK-8 ,コロニー形成 ,フローサイトメトリー ,およびトランスウェル測定を用いて細胞生存 ,アポトーシス ,移住 ,および侵入を評価した.
- 代謝変化 (ATP,乳酸,グルコース吸収) とウエスタン・ブロットとqRT-PCRによる遺伝子/タンパク質発現を分析した.
主要な成果:
- テアフラビン (TF) は,CRC細胞の侵入,移動および増殖の投与量および時間依存の抑制を示した.
- Bcl-2,Bax,Cleaved Caspase-3,Caspase-9の発現を調節することによって,TFが誘発したアポトーシス.
- 生物情報学では,DDIT4が糖分分解と正に相関する重要な標的遺伝子として特定され,TFはDDIT4をダウンレギュレーションし,CRCの糖分分解と増殖を抑制した.
結論:
- テアフラビン (TF) はDDIT4を標的とし,糖分分解活性を調節することで,結腸直腸がん (CRC) の進行を抑制する.
- TFのCRC細胞の増殖,侵入,移動を抑制する能力は,DDIT4と糖分解への影響と併せて,その治療の可能性を強調しています.
- DDIT4の過剰発現は,TFの抑制効果を部分的に逆転させ,TF媒介によるCRC抑制におけるその役割を確認した.
さらに関連する動画
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
5.7K
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
1.1K
関連する概念動画
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.2K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
